Showing results (371-380 of 380) with videos related to
Sort By:
Pageof 38
You have reached the last page of results.This site can display upto 380 results.
Nature Medicine|June 21, 2020
Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanomaDavid Liu, Bastian Schilling, Derek Liu, et al.European Journal of Cancer (Oxford, England : 1990)|January 28, 2025
Clinical outcomes and management following progressive disease with anti-PD-(L)1 therapy in patients with advanced Merkel Cell CarcinomaJeremy Mo, Anne Zaremba, Andrisha-Jade Inderjeeth, et al.European Journal of Cancer (Oxford, England : 1990)|May 10, 2021
The role of local therapy in the treatment of solitary melanoma progression on immune checkpoint inhibition: A multicentre retrospective analysisJudith M Versluis, Anne M Hendriks, Alison M Weppler, et al.European Journal of Cancer (Oxford, England : 1990)|January 26, 2024
Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapySarah K Jacques, Janet McKeown, Piyush Grover, et al.Med (New York, N.Y.)|January 24, 2023
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitorsNicolas Gonzalo Nuñez, Fiamma Berner, Ekaterina Friebel, et al.Science Advances|November 27, 2024
Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanomaGiuseppe Tarantino, Cora A Ricker, Annette Wang, et al.Journal for Immunotherapy of Cancer|July 6, 2022
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanomaPrachi Bhave, Tasnia Ahmed, Serigne N Lo, et al.Journal for Immunotherapy of Cancer|May 4, 2026
Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastasesMario Mandalà, Monica F Chen, Ryan J Sullivan, et al.Journal for Immunotherapy of Cancer|January 20, 2021
Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibitionAljosja Rogiers, Ines Pires da Silva, Chiara Tentori, et al.European Journal of Cancer (Oxford, England : 1990)|December 6, 2024
Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy - A multicenter study on 2419 patients from the prospective skin cancer registry ADORegJulian Kött, Tim Zell, Noah Zimmermann, et al.Pageof 38